This is a non-core endpoint: only basic statistics are computed.
Other sex chromosome abnormalities, female phenotype, not elsewhere classified
Q17_OTHER_SEX_CHROMOSOME_ABNORMALITI_FEMALE_PHENOT_NOT_ELSEW_CLASSIFIED
No definition available.
Endpoint definition
↥
FinnGen phenotype data
429209 individuals
Apply sex-specific rule None
429209
Check conditions None
429209
Check pre-conditions, main-only, mode, registry filters
2 out of 7 registries used, show all original rules.
24
Check minimum number of events None
24
Include endpoints None
24
Remove individuals based on genotype QC
22
Q17_OTHER_SEX_CHROMOSOME_ABNORMALITI_FEMALE_PHENOT_NOT_ELSEW_CLASSIFIED
Control definitions
Control exclude
Q17_CHROMOSOMAL_ABNORMALITI_NOT_ELSEW_CLASSIFIED
Extra metadata
Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF4
Parent code in ICD-10
Q9
Name in latin
Aliae abnormitates chromosomatum sexualium patientis phaenotypo femininae non alibi classificatae
Show upset plot detailing case counts by codes
Or the full data table
Similar endpoints
↥List of similar endpoints to
Other sex chromosome abnormalities, female phenotype, not elsewhere classified
based on the number of shared cases.
Broader endpoints:
- Chromosomal abnormalities, not elsewhere classified
- Congenital malformations, deformations and chromosomal abnormalities
- Any event in hilmo or specialist outpatient
- Any prescribed medicine buy
Narrower endpoints:
None
Summary Statistics
↥Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 22 | 22 | - |
| Unadjusted prevalence (%) | 0.01 | 0.01 | - |
| Mean age at first event (years) | 28.77 | 28.77 | - |
Mortality
Not a core endpoint, no data to show.
Age distribution of first events
Year distribution of first events
Cumulative Incidence
Not a core endpoint, no data to show.
Correlations
↥
Index endpoint: Q17_OTHER_SEX_CHROMOSOME_ABNORMALITI_FEMALE_PHENOT_NOT_ELSEW_CLASSIFIED – Other sex chromosome abnormalities, female phenotype, not elsewhere classified
GWS hits:
Survival analyses between endpoints
↥Not a core endpoint, no data to show.
Drugs most likely to be purchased after Other sex chromosome abnormalities, female phenotype, not elsewhere classified
↥Endpoint not on priority list, no data to show.